5 Results for "

BCLAF1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "BCLAF1" in MCE Product Catalog:

Cat. No.: HY-RS01445
Research Areas:  

Others

BCLAF1 Human Pre-designed siRNA Set A contains three designed siRNAs for BCLAF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS21100
Research Areas:  

Others

Bclaf1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bclaf1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS27618
Research Areas:  

Others

Bclaf1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bclaf1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P87468
Synonyms: BTF, KIAA0164, BCLAF1, Bcl-2-associated transcription factor 1, Btf, BCLAF1 and THRAP3 family member 1

Host:  

Rabbit

Application:  

WB, IHC-P, IHC-F, ICC/IF, IF-Tissue

Reactivity:  

Human, Mouse, Rat

Cat. No.: HY-183831
CAS No.: 3034312-19-8
Research Areas:  

Cancer

GPS167 is a CLK kinase inhibitor that potently and selectively inhibits recombinant human CLK1, CLK2 and CLK4. By inhibiting CLK-mediated phosphorylation of SRSF10, GPS167 upregulates the protein-binding ability of CLK1 and CLK4 with SRSF10, downregulates oncogenic BCLAF1-L and upregulates tumor-suppressive BCLAF1-S, regulates alternative splicing of genes such as MDM2 and MDM4, stabilizes p53 protein and induces DNA damage, ultimately triggering tumor cell apoptosis. GPS167 can block the epithelial-mesenchymal transition process of tumors, activate intracellular double-stranded RNA-mediated antiviral immune responses, and produce synergistic cytotoxicity when combined with microtubule-targeting drugs. GPS167 can be used in research related to various cancers including colorectal cancer [1] .